PRME

Prime Medicine (PRME)

About Prime Medicine (PRME)

Prime Medicine, Inc. is a biotechnology company, which engages in developing one-time curative genetic therapies. The company was founded by David R. Liu on September 13, 2019 and is headquartered in Cambridge, MA.

Details

Daily high
$3.58
Daily low
$3.43
Price at open
$3.51
52 Week High
$6.94
52 Week Low
$1.11
Market cap
646.4M
Dividend yield
0.00%
Volume
11,415
Avg. volume
3.2M
P/E ratio
-2.61

Prime Medicine News

Details

Daily high
$3.58
Daily low
$3.43
Price at open
$3.51
52 Week High
$6.94
52 Week Low
$1.11
Market cap
646.4M
Dividend yield
0.00%
Volume
11,415
Avg. volume
3.2M
P/E ratio
-2.61